WO2004104595A3 - Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) - Google Patents
Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) Download PDFInfo
- Publication number
- WO2004104595A3 WO2004104595A3 PCT/EP2004/004964 EP2004004964W WO2004104595A3 WO 2004104595 A3 WO2004104595 A3 WO 2004104595A3 EP 2004004964 W EP2004004964 W EP 2004004964W WO 2004104595 A3 WO2004104595 A3 WO 2004104595A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorders
- diseases
- pepd
- therapeutics
- diagnostics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04731927A EP1629282A2 (en) | 2003-05-22 | 2004-05-10 | Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03011593.5 | 2003-05-22 | ||
EP03011593 | 2003-05-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004104595A2 WO2004104595A2 (en) | 2004-12-02 |
WO2004104595A3 true WO2004104595A3 (en) | 2005-04-28 |
Family
ID=33462086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/004964 WO2004104595A2 (en) | 2003-05-22 | 2004-05-10 | Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1629282A2 (en) |
WO (1) | WO2004104595A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3001805B1 (en) * | 2013-02-01 | 2015-02-20 | Biomerieux Sa | METHOD FOR DETECTING COLORECTAL CANCER |
ES2711558T3 (en) * | 2013-08-26 | 2019-05-06 | Health Research Inc | Method of prevention and / or treatment of ErbB2-positive cancers |
EP3183342B1 (en) * | 2014-08-20 | 2021-05-12 | Health Research, Inc. | Method for prophylaxis and/or treatment of erbb1 positive cancers |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011799A2 (en) * | 1997-09-02 | 1999-03-11 | Medical College Of Georgia Research Institute, Inc. | Human aminopeptidase p gene |
WO2002061131A2 (en) * | 2000-12-04 | 2002-08-08 | Bristol-Myers Squibb Company | Human single nucleotide polymorphisms |
US20020137120A1 (en) * | 2000-10-31 | 2002-09-26 | Brown Nancy J. | Biological markers and diagnostic tests for angiotensin converting enzyme inhibitor-and vasopeptidase inhibitor-associated angioedema |
-
2004
- 2004-05-10 WO PCT/EP2004/004964 patent/WO2004104595A2/en active Application Filing
- 2004-05-10 EP EP04731927A patent/EP1629282A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011799A2 (en) * | 1997-09-02 | 1999-03-11 | Medical College Of Georgia Research Institute, Inc. | Human aminopeptidase p gene |
US20020137120A1 (en) * | 2000-10-31 | 2002-09-26 | Brown Nancy J. | Biological markers and diagnostic tests for angiotensin converting enzyme inhibitor-and vasopeptidase inhibitor-associated angioedema |
WO2002061131A2 (en) * | 2000-12-04 | 2002-08-08 | Bristol-Myers Squibb Company | Human single nucleotide polymorphisms |
Non-Patent Citations (1)
Title |
---|
VENEMA ET AL: "Cloning and tissue distribution of human membrane-bound aminopeptidase P", BIOCHIMICA ET BIOPHYSICA ACTA . GENE STRUCTURE AND EXPRESSION, ELSEVIER, AMSTERDAM, NL, vol. 1354, no. 1, 1997, pages 45 - 48, XP002095023, ISSN: 0167-4781 * |
Also Published As
Publication number | Publication date |
---|---|
EP1629282A2 (en) | 2006-03-01 |
WO2004104595A2 (en) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004104216A3 (en) | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) | |
WO2005106012A3 (en) | Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1) | |
WO2005114207A3 (en) | Diagnostics and therapeutics for diseases associated with aminopeptidase n (anpep) | |
WO2005100990A3 (en) | Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2) | |
WO2005106491A3 (en) | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1) | |
WO2005078117A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 6 (klk6) | |
WO2005075675A3 (en) | Diagnostics and therapeutics for diseases associated with putative cysteine protease 1 (prs1) | |
WO2005085466A3 (en) | Diagnostic and therapeutics for diseases associated with rho-associated protein kinase 2 (rock2) | |
WO2005075662A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 2 (klk2) | |
WO2004097358A3 (en) | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) | |
WO2004104595A3 (en) | Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) | |
WO2005022164A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8) | |
WO2005090994A3 (en) | Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1) | |
WO2005113786A3 (en) | Diagnostics and therapeutics for diseases associated with chymase (cma1) | |
WO2004104574A3 (en) | Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 7 (ccr7) | |
WO2005085469A3 (en) | Diagnostics and therapeutics for diseases associated with rho-associated protein kinase 1 (rock1) | |
WO2006013013A3 (en) | Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb) | |
WO2006013014A3 (en) | Diagnostics and therapeutics for diseases associated with prostate-specific membrane antigen-like protein (psmal) | |
WO2005076003A3 (en) | Diagnostics and therapeutics for diseases associated with plasma glutamate carboxypeptidase (pgcp) | |
WO2005059546A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) | |
WO2005073729A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y11 (p2y11) | |
WO2004080374A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) | |
WO2005095631A3 (en) | Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 alpha (mlk4 alpha) | |
WO2005026719A3 (en) | Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3) | |
WO2006013016A3 (en) | Diagnostics and therapeutics for diseases associated with eosinophil serine protease 1 (prss21) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004731927 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004731927 Country of ref document: EP |